Discover the key findings from the DEA's 2022 Annual Toxicology Testing Program report, highlighting emerging drug trends like Para-Fluorofentanyl, Metonitazene, Bromazolam, Clonazolam, and the misuse of Xylazine.
Share this post
DEA's 2022 Toxicology Report: Trends and…
Share this post
Discover the key findings from the DEA's 2022 Annual Toxicology Testing Program report, highlighting emerging drug trends like Para-Fluorofentanyl, Metonitazene, Bromazolam, Clonazolam, and the misuse of Xylazine.